triple

Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox

indie 14 October

3 minutes

SYDNEY, Oct 14, 2021 – (ACN Newswire via SEAPRWire.com) – Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment […]

ACN Newswire

Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors

indie 8 September

6 minutes

NEW JERSEY, the U.S. and HANGZHOU, China, Sep 8, 2021 – (ACN Newswire via SEAPRWire.com) – Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced […]